| All About Eyes | |
|
42201 N 41st Dr, Suite 144, Anthem, AZ 85086-3800 | |
| (623) 551-9122 | |
| (623) 551-9120 |
| Full Name | All About Eyes |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 42201 N 41st Dr, Anthem, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902133739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1174 (Arizona) | Primary |
| Provider Name | Thomas R Czyz |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1558470583 PECOS PAC ID: 5991603326 Enrollment ID: I20031223000244 |
News Archive
Leukemias are debilitating cancers of the hematopoietic or blood-forming cells of the bone marrow. Now, researchers at Tokyo Medical and Dental University describe an ingenious strategy against chronic myelomonocytic leukemia (CMML) wherein an antibody-drug conjugate (ADC) comprising a cytotoxic drug payload linked to an antibody that selectively targets specific cell lines effectively blocks malignant cell proliferation at source.
Using spider toxins to study the proteins that let nerve cells send out electrical signals, Johns Hopkins researchers say they have stumbled upon a biological tactic that may offer a new way to protect crops from insect plagues in a safe and environmentally responsible way.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
A study led by Edward Wojcik, PhD, Associate Professor of Biochemistry & Molecular Biology at LSU Health New Orleans School of Medicine, identified how microcephaly (abnormally small heads) and blindness may develop in Zika-infected fetuses, as well as a new way to potentially prevent these neurodevelopmental defects.
Applied Spine Technologies announced today the first two Stabilimax surgeries performed outside of the United States. The surgeries were performed in Johannesburg, South Africa, by Ajay Maharaj, MD, at Sunninghill Hospital. The Stabilimax Dynamic Spine System is currently part of an IDE multi-center, randomized, controlled clinical trial in the U.S.
› Verified 8 days ago
| Provider Name | David P Shibata |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1841397973 PECOS PAC ID: 7911973649 Enrollment ID: I20040903000666 |
News Archive
Leukemias are debilitating cancers of the hematopoietic or blood-forming cells of the bone marrow. Now, researchers at Tokyo Medical and Dental University describe an ingenious strategy against chronic myelomonocytic leukemia (CMML) wherein an antibody-drug conjugate (ADC) comprising a cytotoxic drug payload linked to an antibody that selectively targets specific cell lines effectively blocks malignant cell proliferation at source.
Using spider toxins to study the proteins that let nerve cells send out electrical signals, Johns Hopkins researchers say they have stumbled upon a biological tactic that may offer a new way to protect crops from insect plagues in a safe and environmentally responsible way.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
A study led by Edward Wojcik, PhD, Associate Professor of Biochemistry & Molecular Biology at LSU Health New Orleans School of Medicine, identified how microcephaly (abnormally small heads) and blindness may develop in Zika-infected fetuses, as well as a new way to potentially prevent these neurodevelopmental defects.
Applied Spine Technologies announced today the first two Stabilimax surgeries performed outside of the United States. The surgeries were performed in Johannesburg, South Africa, by Ajay Maharaj, MD, at Sunninghill Hospital. The Stabilimax Dynamic Spine System is currently part of an IDE multi-center, randomized, controlled clinical trial in the U.S.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| All About Eyes 42201 N 41st Dr, Suite 144, Anthem, AZ 85086-3800 Ph: (623) 551-9122 | All About Eyes 42201 N 41st Dr, Suite 144, Anthem, AZ 85086-3800 Ph: (623) 551-9122 |
News Archive
Leukemias are debilitating cancers of the hematopoietic or blood-forming cells of the bone marrow. Now, researchers at Tokyo Medical and Dental University describe an ingenious strategy against chronic myelomonocytic leukemia (CMML) wherein an antibody-drug conjugate (ADC) comprising a cytotoxic drug payload linked to an antibody that selectively targets specific cell lines effectively blocks malignant cell proliferation at source.
Using spider toxins to study the proteins that let nerve cells send out electrical signals, Johns Hopkins researchers say they have stumbled upon a biological tactic that may offer a new way to protect crops from insect plagues in a safe and environmentally responsible way.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
A study led by Edward Wojcik, PhD, Associate Professor of Biochemistry & Molecular Biology at LSU Health New Orleans School of Medicine, identified how microcephaly (abnormally small heads) and blindness may develop in Zika-infected fetuses, as well as a new way to potentially prevent these neurodevelopmental defects.
Applied Spine Technologies announced today the first two Stabilimax surgeries performed outside of the United States. The surgeries were performed in Johannesburg, South Africa, by Ajay Maharaj, MD, at Sunninghill Hospital. The Stabilimax Dynamic Spine System is currently part of an IDE multi-center, randomized, controlled clinical trial in the U.S.
› Verified 8 days ago
Dr. Thuy Ngoc Yath, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4205 W Anthem Way Ste 101, Anthem, AZ 85086 Phone: 623-879-3937 Fax: 623-551-2051 | |
Anthem Eye Group Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4205 W Anthem Way #101, Anthem, AZ 85086 Phone: 623-879-3937 Fax: 623-551-1700 | |
Dr. Lawrence R Stern, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3655 W Anthem Way, Ste B149, Anthem, AZ 85086 Phone: 623-879-3937 Fax: 623-551-1700 | |
All About Eyes Optometrist Medicare: Not Enrolled in Medicare Practice Location: 42201 N 41st Dr Ste 144, Anthem, AZ 85086 Phone: 623-551-9122 Fax: 623-551-9120 | |
Svetlana V Aleshina, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4435 W Anthem Way, Anthem, AZ 85086 Phone: 623-551-6334 Fax: 623-551-6338 | |
Thomas R Czyz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 42201 N 41st Dr, Suite 124-128, Anthem, AZ 85086 Phone: 623-551-9122 Fax: 623-551-9120 | |
Better Vision Eyecare, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 4205 W Anthem Way Ste 101, Anthem, AZ 85086 Phone: 623-879-3937 Fax: 623-551-2051 |